CSI Market
Sign In | Register

Dexcom Inc (DXCM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DXCM Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Dexcom Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
9 Months 		(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Operating Activities
Income723.70
Depreciation & amortization209.80
Amortization of Other Assets2.90
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories146.80
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation119.10
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest3.10
Fair Value Of Contingent Consideration-
R Dexpensethroughissuanceofcommonstock-
Collaborative Research And Development Fee-
Equity Securities Fv Ni Realized Gain Loss-
Equity Securities Fv Ni Gain Loss-
Income taxes0.00
Equity Method Investment, Realized Gain (Loss) on Disposal0.00
Accounts Receivable-31.10
Increase (Decrease) in Accounts Payable and Accrued Liabilities144.40
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-51.00
Other Working Capital-11.00
Other Noncash Income (Expense)-6.80
Other net0.00
Payments for (Proceeds from) Other Operating Activities-129.50
Discontinued operations0.00
Net Cash flow from Operating Activities1,120.40
Investing Activities
Capital Expenditures-214.20
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities1,160.90
Payments to Acquire Available-for-sale Securities, Debt-941.40
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments-9.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-41.20
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-45.40
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-978.90
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-44.90
Other net0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents919.10
Purchase Of Convertible Note Hedge-
Purchase of Convertible Note Hedge-
Payments for Repurchase of Convertible Notes-
Payments For Repurchase Of Convertible Notes-
Payments For Purchases Of Capped Call Transactions-
Repayments For Maturity Of Senior Convertible Notes-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1,023.80
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow906.20
Total Cash Flow42.40
4 historic quarters locked

Sign in to unlock the full Dexcom Inc cash flow history.

Sign In Create Free Account

About Dexcom Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001093557-26-000195

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI